Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

about

BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.

P2860

Q38816142-6BE6504E-2E80-4F57-91C2-7C75CBC0719D Q38817974-A10D8D35-2000-4AD2-BE5E-8F1AB8C5C176

P2860

Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

Item

http://www.wikidata.org/entity/Q39087605

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@en

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@nl

type

Item

label

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@en

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@nl

prefLabel

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@en

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells.

@nl

P1476

Anti-EGFR therapy combined wit ...... of DAOY medulloblastoma cells

@en

P2093

Algemir Lunardi Brunetto

http://www.w3.org/2001/XMLSchema#string

Carolina Nör

http://www.w3.org/2001/XMLSchema#string

Caroline Brunetto de Farias

http://www.w3.org/2001/XMLSchema#string

Mariane Jaeger

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Molecular subgroups of medulloblastoma: the current consensus

Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification

Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles.

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.

Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1

Medulloblastoma: signalling a change in treatment.

Altered molecular pathways in gliomas: an overview of clinically relevant issues.

P2888

s00381-013-2290-6

P304

2145-2150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00381-013-2290-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Lucia Abujamra

Gilberto Schwartsmann

R Roesler

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257350403

http://www.w3.org/2001/XMLSchema#string

P698

24092425

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

about

P2860

P2860

Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921